U.S., March 26 -- An application to own the trademark for 'EPIXIENNE' has been filed on Aug. 12, 2022.
Owner(s):
Bayer Aktiengesellschaft; Kaiser-Wilhelm-Allee, 1, , GERMANY
Goods and/or Services:
For: Pharmaceutical preparations for humans for treatment of gynecological pain diseases and inflammatory diseases, disorders, and deficiencies; pharmaceutical preparations for humans for treatment of cardiological pain and inflammatory diseases, disorders, and deficiencies; pharmaceutical preparations for treatment of cystic, pain, and inflammatory diseases of the kidney; pharmaceutical preparations for humans for treatment of pain and inflammation caused by hormone related disorders, cancer, or genetic deficiencies; none of the foregoing inc...